Charles Retina Institute is a clinical research site located in Germantown, Tennessee, United States 38138.
Crixeo Health Trust Score: 85/100 (GOOD). This profile has not yet been claimed by the site owner.
Charles Retina Institute has participated in 42 clinical trials with 18 currently active.
Therapeutic areas: Diabetic Retinopathy, Neovascular Age-related Macular Degeneration, Diabetic Macular Edema.
Sponsors: Greater Houston Retina Research, Ocular Therapeutix, Inc., Genentech, Inc..
Trust Score: 85/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
Charles Retina Institute has a Crixeo Trust Score of 85/100 (GOOD). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Charles Retina Institute has 42 clinical trials on record, with 18 currently active. Their work covers Diabetic Retinopathy, Neovascular Age-related Macular Degeneration, Diabetic Macular Edema.
Charles Retina Institute has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.